Sangamo Therapeutics Inc Clinical Development Update Call Transcript
Good day, and welcome to the Sangamo Therapeutics clinical development update conference call. This call is being recorded.
I will now pass you over to the coordinator of this event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.
Hello, and thank you for joining us.
As we begin, I'd like to point out that we will be referencing an accompanying slide presentation today. A link to the slide presentation may be found on our website, sangamo.com, on the Events and Presentations page of the Investors + Media section of the site.
I'd also like to remind everyone that the forward-looking statements that we will discuss during this conference call are based upon the information that we have available today. Forward-looking statements include, but are not limited to, statements related to the potential therapeutic applications for Sangamo's genomic medicine platform, the potential ability of Sangamo's product
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |